MC
PRAH

Maverick Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Maverick Capital’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-224
Closed -$34K – 905
2021
Q1 		$34K Buy
+224
New +$30.4K ﹤0.01% 657
2020
Q3 		– Sell
-7,010
Closed -$682K – 737
2020
Q2 		$682K Buy
+7,010
New +$652K 0.01% 408

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Maverick Capital's PRAH Position: Q2 2021 in Review

Maverick Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 224 shares — an estimated $34K sold.

Maverick Capital first reported a position in PRAH in Q2 2020 and held it in 2 quarters. The position peaked at $682K in Q2 2020. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Maverick Capital reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Maverick Capital sold 224 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $34K.
  • Maverick Capital first reported a position in PRA Health Sciences, Inc. in Q2 2020 and held it in 2 quarters.
  • Maverick Capital's PRA Health Sciences, Inc. position peaked at $682K in Q2 2020.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Maverick Capital's 13F filing for Q2 2021, filed 16 Aug 2021.